Martingale Asset Management L P cut its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 6.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 132,126 shares of the medical research company’s stock after selling 9,789 shares during the quarter. Martingale Asset Management L P’s holdings in Thermo Fisher Scientific were worth $23,053,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Thermo Fisher Scientific by 2.7% in the first quarter. Vanguard Group Inc. now owns 25,971,301 shares of the medical research company’s stock worth $3,989,193,000 after buying an additional 695,079 shares during the period. BlackRock Inc. boosted its position in shares of Thermo Fisher Scientific by 2,692.1% in the first quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock worth $3,531,095,000 after buying an additional 22,165,530 shares during the period. State Street Corp boosted its position in shares of Thermo Fisher Scientific by 1.0% in the first quarter. State Street Corp now owns 16,085,954 shares of the medical research company’s stock worth $2,470,802,000 after buying an additional 164,367 shares during the period. Wellington Management Group LLP boosted its position in shares of Thermo Fisher Scientific by 5.6% in the first quarter. Wellington Management Group LLP now owns 7,512,152 shares of the medical research company’s stock worth $1,153,867,000 after buying an additional 398,622 shares during the period. Finally, Morgan Stanley boosted its position in shares of Thermo Fisher Scientific by 7.6% in the first quarter. Morgan Stanley now owns 4,664,882 shares of the medical research company’s stock worth $716,526,000 after buying an additional 327,826 shares during the period. 83.32% of the stock is owned by institutional investors and hedge funds.

Thermo Fisher Scientific Inc (NYSE TMO) opened at 191.28 on Tuesday. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $194.30. The company has a market capitalization of $74.62 billion, a price-to-earnings ratio of 33.32 and a beta of 1.05. The firm’s 50-day moving average price is $189.61 and its 200 day moving average price is $175.55.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.27 by $0.03. The firm had revenue of $5 billion during the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The company’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same period in the prior year, the business earned $2.03 EPS. On average, equities research analysts expect that Thermo Fisher Scientific Inc will post $9.35 EPS for the current fiscal year.

Several brokerages have recently commented on TMO. Jefferies Group LLC reaffirmed a “hold” rating and issued a $195.00 target price on shares of Thermo Fisher Scientific in a research report on Thursday, September 28th. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $197.00 target price for the company in a research report on Tuesday, August 1st. Leerink Swann raised their target price on Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research report on Monday, October 9th. BidaskClub cut Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Finally, Barclays PLC reaffirmed an “overweight” rating and issued a $200.00 target price (up previously from $190.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 17th. One analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $203.64.

In other news, SVP Gregory J. Herrema sold 30,000 shares of the stock in a transaction dated Wednesday, August 2nd. The shares were sold at an average price of $176.02, for a total transaction of $5,280,600.00. Following the completion of the transaction, the senior vice president now directly owns 67,016 shares in the company, valued at approximately $11,796,156.32. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, VP Seth H. Hoogasian sold 4,140 shares of the stock in a transaction dated Monday, August 28th. The stock was sold at an average price of $177.80, for a total transaction of $736,092.00. Following the transaction, the vice president now owns 25,518 shares of the company’s stock, valued at $4,537,100.40. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 52,738 shares of company stock valued at $9,302,112. Company insiders own 0.49% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://www.watchlistnews.com/martingale-asset-management-l-p-trims-stake-in-thermo-fisher-scientific-inc-tmo/1635811.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.